Risks and benefits: Interview with John Campbell
- Norman Fenton
- Dec 12, 2022
- 1 min read
Had a great discussion with John Campbell today about different measures of risk (e.g. absolute risk reduction, relative risk reduction, number needed to treat) and the importance of understanding the difference between them in order to know whether a medical treatment is safe and effective.
It's also on John's channel (he has 2.6 million subscribers so there are a lot more views and comments there!)
Has Prof. Fenton looked at the efficacy (numbers to treat, rate of adverse reaction, absolute risk reduction and so on) of the 'vaccines' to protect against severity and mortality, especially in older people? In a recent interview on Unherd TV, the Oxford professor Gupta, one of the signatories to the Great Barrington Declaration, repeated three times that the mRNA vaccines (which she said are actually vaccines, although of a new kind) protected vulnerable groups against severity and mortality of Covid-19 illness. This is not what the analysis group organized by Dr. Naomi Wolf looking at Pfizer's own research as presented to the FDA found. Nor what Ed Dowd found. I would be VERY interested in hearing what Prof. Fenton's understandin…
Can't wait for any work you can do on under-reporting of deaths and adverse events! the number of cases (and deaths with C19 present?) are declining as testing is, presumably, only done in a clinical setting, (hospital waiting list = >6months?, doctor waiting list = ?) - but I swear it looks like anything and everything is being done to PREVENT analysis - because if the analysis is ever made public the sheer enormity of poor decision making resulting in unnecessary death and suffering will become undeniable. Then there is the issue of "Liverpool pathway" treatment protocols involving Midazolam and morphine - the MHRA advised against Midazolam one month before the NICE, NHS, (some board or other of) Doctors an…